Advisor Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Advisor Partners’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,468	Closed	-$222K	–	611
2017 Q4	$222K	Sell	3,468 -391	-10%	-$21.4K	0.04%	501
2017 Q3	$220K	Buy	3,859 +21	+0.5%	+$1.23K	0.04%	439
2017 Q2	$231K	Buy	+3,838	New	+$219K	0.05%	410

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Advisor Partners's BIVV Position: Q1 2018 in Review

Advisor Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,468 shares — an estimated $222K sold.

Advisor Partners first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $231K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Advisor Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Advisor Partners sold 3,468 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $222K.
Advisor Partners first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Advisor Partners's Bioverativ Inc. Common Stock position peaked at $231K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Advisor Partners's 13F filing for Q1 2018, filed 3 May 2018.